Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon

British Journal of Haematology

Volumn 117, Issue 4, 2002, Pages 940-946

  Gadisseur, Alain P A ^a,b   Van Der Meer, Felix J M ^a,b   Adriaansen, Henk J ^c   Fihn, Stephan D ^a   Rosendaal, Frits R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Leiden Anticoagulation Clinic   (Netherlands)

^c Franciscus Hospital   (Netherlands)

Author keywords

Acenocoumarol; Matched comparison; Phenprocoumon; Quality of anticoagulation

Indexed keywords

ACENOCOUMAROL; LONG ACTING DRUG; PHENPROCOUMON; SINTROM MITIS;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE SEVERITY; DRUG FATALITY; DRUG QUALITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; THROMBOEMBOLISM;

ACENOCOUMAROL; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CONFIDENCE INTERVALS; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; PHENPROCOUMON;

EID: 0036283541     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03493.x     Document Type: Article

References (24)

1. Therapeutic control of oral anticoagulant treatment in The Netherlands
2. A comparative study concerning the stability of the anticoagulant effect of acenocoumarol and phenprocoumon
3. Optimal oral anticoagulant therapy in patients with mechanical heart valves
4. The risk of emergency intestinal bleeding among users of acenocoumarin: A population-based cohort study
5. Experience with the anticoagulant Marcumar
6. Comparative study of the clinical effect of acenocoumarol (Sintrom) and phenprocoumon (Marcoumar) in myocardial infarction and angina pectoris
7. Risk factors for complications of chronic anticoagulation
8. The risk for and severity of bleeding complications in elderly patients treated with warfarin
9. Clinically important drug interactions with anticoagulants. An update
10. The mechanism of action of oral anticoagulants and its consequences for the practice of oral anticoagulation
11. Effect of oral anticoagulants on factors VII, IX, X and II
12. Clinical pharmakokinetics of oral anticoagulants
13. Behaviour of Factors II, VII, IX and X during Long-Term Treatment with Coumarin
14. Anticoagulant control and the risk of bleeding
15. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
16. Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants
17. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy
18. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol)
19. Phenprocoumon. Diphenadione, Warfarin and Bishydroxycoumarin: A comparative study
20. A method to determine the optimal intensity of oral anticoagulant therapy
21. Five-year study of anticoagulants
22. How effective is clinical control of anticoagulant therapy?
23. 4-Hydroxycoumarin oral anticoagulants: Pharmacokinetics-response relationship
24. A computer program for long term anticoagulation control